Lipoproteins; Very Low Density; Human Plasma

General description

Native very low density lipoproteins from human plasma. VLDL transports liver-synthesized triglycerides and cholesterol. May counteract the inhibitory effect of glucocorticoids on arachidonic acid release and prostaglandin I₂ formation in vascular smooth muscle cells. Composition: 88-95% lipid; 5-12% protein.

A 5 mg vial contains ~1 mg of protein.

Native very low density lipoproteins from human plasma. VLDL transports hepatic synthesized triglycerides and cholesterol. May counteract the inhibitory effect of glucocorticoids on arachidonic acid release and prostaglandin I2 formation in vascular smooth muscle cells. (Composition: 88-95% lipid; 5-12% protein. Note: 5 mg vial contains 1 mg of protein.)

Legal Information

CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany

Other Notes

Petrichenko, I., et al. 1993. Biochim. Biophys. Acta1166, 183.

Packaging

5 mg in Plastic ampoule

Please refer to vial label for lot-specific concentration.

Warning

Toxicity: Standard Handling (A)